Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Hisaki Shimada"'
Autor:
Yohei Tsuchida, Yutaka Tsubata, Ryosuke Nozawa, Shuntaro Maruyama, Kouzo Ikarashi, Noriko Saito, Tetsuo Morioka, Takeshi Kamura, Hisaki Shimada, Ichiei Narita
Publikováno v:
CEN Case Reports.
Autor:
Ken-ichi Konishi, Kouzo Ikarashi, Mutsumi Ike, Yutaka Tsubata, Noriko Saito, Masaru Nakamura, Tetsuo Morioka, Hisaki Shimada
Publikováno v:
Nihon Toseki Igakkai Zasshi. 54:561-570
Autor:
Naohito Tanabe, Michihiro Hosojima, Tetsuya Takasawa, Ichiei Narita, Yuta Yoshizawa, Takahito Ito, Daisuke Ugamura, Hisaki Shimada, Yoshiki Suzuki, Yutaka Koda, Tadahiro Kitamura, Hideyuki Kabasawa, Masaki Kobayashi, Akihiko Saito
Publikováno v:
Diabetes Therapy
Introduction Dipeptidyl peptidase 4 (DPP4) inhibitors are widely used in patients with type 2 diabetes mellitus (T2DM) on maintenance hemodialysis (HD), but the efficacy of the once-weekly DPP4 inhibitor omarigliptin is not known. Methods This prospe
Autor:
Naoki Imada, Ken Igawa, Hisaki Shimada, Noritomo Itami, Ryoko Takubo, Eriko Kinugasa, Morihiro Kondo, Yuichi Kawata, Hiroyuki Murota, Satoshi Funakoshi, Naoki Fukazawa
Publikováno v:
Clinical and Experimental Nephrology
Background The pathophysiology of uremic pruritus (UP), which is characterized by systemic and intractable itching, remains unclear. As interleukin (IL)-31 may be involved, we conducted a phase II, randomized, controlled study to evaluate nemolizumab
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims In hemodialysis (HD) patients without residual renal function, almost all of phosphate (P) absorbed through intestine is eliminated with HD. To avoid hyperphosphatemia, which is major risk for mortality in HD patients, reduced P a
Autor:
Katsuharu Hatada, Taku Matsubara, Tetsuo Morioka, Yutaka Tsubata, Hisaki Shimada, Wataru Mitsuma, Noriko Saito, Kozo Ikarashi, Makoto Tamura, Shigeru Miyazaki, Shunsuke Imai
Publikováno v:
Internal Medicine. 57:2295-2300
Objective The progress of non-anticoagulated patients with atrial fibrillation (AF) undergoing hemodialysis has not been determined. Using data from the RAKUEN (Registry of Atrial fibrillation in chronic Kidney disease Under hEmodialysis from Niigata
Autor:
Hisaki Shimada, Ichiei Narita, Yutaka Tsubata, Shinji Sakai, Noriko Saito, Hiroki Yamaguchi, Kouzou Ikarashi, Tetsuo Morioka, Kazuhiro Yoshita
Publikováno v:
CEN case reports. 8(1)
Hypermagnesemia is generally considered an exceptional iatrogenic condition usually caused by magnesium-containing cathartics. In particular, this condition often develops when magnesium-containing cathartics are administered to elderly patients with
Autor:
Tetsuo Morioka, Yasuko Toyoshima, Taiji Sasagawa, Yutaka Tsubata, Ichiei Narita, Hisaki Shimada, Noriko Saito, Shigeru Miyazaki, Takashi Morita, Hajime Tanaka, Kouzo Ikarashi, Shinji Sakai, Rie Saito, Hiroaki Nozaki
Publikováno v:
CEN case reports. 7(1)
Retinal vasculopathy with cerebral leukodystrophy (RVCL) is a rare autosomal dominant systemic microvascular disease. Neurological disorders and visual disturbance are highlighted as manifestations of RVCL; however, there are few reports focused on n
Publikováno v:
Nephrology Dialysis Transplantation. 32:iii678-iii679
Autor:
Seitaro Iguchi, Hisaki Shimada, Shinichi Nishi, Ichiei Narita, Shin Goto, Takayoshi Miura, Mitsuhiro Ueno
Publikováno v:
Clinical and Experimental Nephrology. 15:86-91
Arg95Stop mutation of exon 4 in complement component 9 (C9) gene is common in individuals in Japan with C9 deficiency (C9D); however, understanding of the influences of C9D on human glomerulonephritis remains elusive. A total of 1288 patients with ch